Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Refractive outcomes comparing primary laser to primary bevacizumab with delayed laser for type 1 ROP.

Anand N, Blair MP, Greenwald MJ, Rodriguez SH. Refractive outcomes comparing primary laser to primary bevacizumab with delayed laser for type 1 ROP. J AAPOS. 2019 04; 23(2):88.e1-88.e6.

View in: PubMed